MARKET

NMRA

NMRA

Neumora Therapeutics Inc
NASDAQ
1.600
-0.030
-1.84%
After Hours: 1.605 +0.005 +0.30% 16:38 07/16 EDT
OPEN
1.620
PREV CLOSE
1.630
HIGH
1.635
LOW
1.590
VOLUME
632.03K
TURNOVER
--
52 WEEK HIGH
3.650
52 WEEK LOW
0.8302
MARKET CAP
296.45M
P/E (TTM)
-1.2060
1D
5D
1M
3M
1Y
5Y
1D
Neumora Therapeutics Is Maintained at Outperform by RBC Capital
Dow Jones · 3d ago
Neumora Therapeutics Price Target Cut to $5.00/Share From $7.00 by RBC Capital
Dow Jones · 3d ago
RBC Capital Maintains Outperform on Neumora Therapeutics, Lowers Price Target to $5
Benzinga · 3d ago
Neumora Therapeutics price target lowered to $5 from $7 at RBC Capital
TipRanks · 3d ago
NEUMORA THERAPEUTICS INC <NMRA.O>: RBC CUTS TARGET PRICE TO $5 FROM $7
Reuters · 3d ago
Weekly Report: what happened at NMRA last week (0706-0710)?
Weekly Report · 3d ago
Datadog, EHang Holdings And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
Benzinga · 07/06 12:02
Weekly Report: what happened at NMRA last week (0629-0703)?
Weekly Report · 07/06 09:25
More
About NMRA
Neumora Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company's therapeutic pipeline consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its advanced product candidate, navacaprant (NMRA-140), is a novel once-daily oral kappa opioid receptor (KOR) antagonist that is being developed for the treatment of depressive disorder (MDD). Navacaprant is being investigated in the KOASTAL pivotal Phase 3 program, evaluating navacaprant monotherapy in patients with moderate to severe MDD. The Company's next advanced product candidate is NMRA-511, which is a highly selective, novel antagonist of the vasopressin 1a receptor (V1aR) being developed for the treatment of agitation associated with dementia due to Alzheimer's disease (AD).

Webull offers Neumora Therapeutics Inc stock information, including NASDAQ: NMRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NMRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NMRA stock methods without spending real money on the virtual paper trading platform.